Professional Documents
Culture Documents
Syncope
Syncope
Management
dr. Astra Dea Simanungkalit, SpS
Learning Objective
Understand definition of syncope.
Know differential diagnosis of syncope.
Know management of uncomplicated
and complicated syncope.
Definiton
Syncope is a sudden transient loss of
consciousness and postural tone with
spontaneous recovery.
Due to reduction blood flow to reticular
activating system in brain stem.
A symptom, not a disease.
Pathophysiology
Normal cerebral blood flow 50-60 ml/100 g
brain tissue (12-15% resting cardiac output)
3-3.5 ml O2/100 g tissue/min.
Decreased cardiac output or peripheral
resistance decreased cerebral perfusion
pressure.
Cardiac output: bradyarrhythmia,
tachyarrhythmia, valvular disease.
Peripheral resistance: thermal stress,
standing, low CO2.
Pathophysiology
Causes of syncope
Causes of syncope
Causes of syncope
Vasovagal syncope
Excessive autonomic reflex (vagal)
activity vasodilataion, bradycardia.
Prodromal: nausea, diaphoresis,
lightheadedness, blurred visions,
headaches, palpitations, paresthesia
and pallor.
Upright position.
Resolves immediately on supine
position.
Washed out, tired feeling after.
Situational
syncope
Glossopharing
eal Neuralgia
Noncardioge
nic syncope
What to do?
Clinical Features
Diagnosis
History taking: associated symptoms
(pre, onset, after), cardiac disease,
metabolic disorders, neurological
disease, setting, drug, family history.
Physical examination.
ECG: rule out arrhythmias,
atrioventricular block.
Echocardiography: structural cardiac
disease.
Orthostatic Test
Orthostatic hypotension associated
with syncope or presyncope.
BP measurements after 5 minutes
lying supine and each minute (3
minute) after standing.
Decrease of > 20 mmHg in SBP or
decrease SBP to < 90 mmHg.
Regardless symptoms occur or not.
When to hospitalize?
Treatment
Education
Avoidance dehydration, stress, alcohol
consumption, extremely warm environment, tight
clothing, anxiety management, coping skills.
Manoeuvres to avert syncope
Drug treatment
blockers, agonists, selective serotonin
reuptake inhibitors, fludrocortisone,
disopyramide, scopolamine, anticholinergic
agents.
Pacemakers
TIA
Syncope
Preonset
Diaphoresis,
lightheadedness,
palpitations, and
pallor
Onset
Tongue biting,
frothing
Dizzines, central
vertigo
TLOC
Blue face
Perioral numbness
Pallor
Tonic/clonic of
extremities
Drop attack,
myoclonic
Diplopia,
dysarthria, limb
weakness, sensory
disturbance
Confusional state
Symptoms
Washed out
Post onset
Aching muscle
tired
Eye deviation
Increased BP and
pulse
Decreased BP and
pulsa
Mortality
Patients with cardiac syncope had the highest
risk of death from any cause and
cardiovascular events.
Structural heart disease is a major RF for
sudden death.
Excellent prognosis:
Young healthy individuals w/o heart disease and normal
ECG.
Neurally mediated syncope.
Orthostatic hypotensipn
Recurrences
35% patients have recurrences of syncope
at 3 years of follow up, 82& occur within
the first 2 years.
Predictor: reccurent >4, psychiatric
diagnosis, age > 45 years, positive tilt
table testing (TTT).
Recurrences are nor associates with
increased mortality.
Further Readings
Eropean Society of Cardiology. Guideline on
Management (Diagnosis and Treatment) of
Syncope Update 2004. Europace
(2004)6:467-537.
Mohamed HA. Syncope: Evaluation and
Management. Libyan J Med AOP: 156-159.
Chen-Scarabelli C, Scarabelli T.
Neurocardiogenic Syncope. BMJ
2004;329:336-41.
Thank you